FDA integrity issues
Subtitle: hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on VISX, Inc. document disclosure, July 31, 1996.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1996
Place of publication: Washington
Language: eng
Number of pages: 83
Subjects: VISX, Inc. -- Trials, litigation, etc.; United States. Food and Drug Administration -- Corrupt practices.; Medical laser industry -- United States.; Criminal investigation -- United States.
Notes: Distributed to some depository libraries in microfiche.
Shipping list no.: 96-0375-P.
"Serial no. 104-93."